Ceramics company SINTX Technologies has developed a new line of silicon nitride products for antipathogenic and biomedical applications.
The FleX SN brand includes FleX SN-MC2, an ultra-dense silicon nitride ceramic used in FDA cleared medical implants, FleX SN-CSC, which features a combined architecture that can mimic the cortical-cancellous structure of bone and is used in FDA cleared medical implants, FleX SN-PEEK, which has the bioactivity of silicon nitride with the properties of conventional polyether ether ketone (PEEK) polymer, and FleX SN-AP, an antipathogenic silicon nitride powder with effective against viruses such as SARS-CoV-2 (COVID-19), with proven mammalian cell compatibility.
‘We continue to focus on developing silicon nitride material properties, product design, and new applications in the biomedical space. Additionally, we have broadened our market focus to identify more antipathogenic and industrial applications for silicon nitride,’ said Dr Sonny Bal, president and CEO.
This story uses material from SINTX, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.
